November 13, 2019
UCLA Health continues to transform cancer care
By uclahealth 
In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson Comprehensive Cancer Center (JCCC) has established an international reputation for providing the best in leading-edge and traditional cancer treatments […]
Tags: advanced lung cancer, breast cancer, CAR T cell therapy, Dr. Antoni Ribas, Dr. Arie Bellgedrun, Dr. Dennis Slamon, Dr. Edward Garon, Dr. Richard Finn, Dr. Sara Hurvitz, HER2-positive, HER2+, Herceptin
October 7, 2019
CAR T-cell therapy: A revolutionary new cancer treatment
By uclahealth
Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma. What is CAR T-cell […]
Tags: cancer, CAR T cell therapy, chimeric antigen receptor, clinical trials, immunotherapy, innovation, research, UCLA Jonsson Comprehensive Cancer Center
February 11, 2019
By uclahealth
Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery. To date, the U.S. Food and Drug Administration (FDA) has approved immunotherapy treatments for 17 cancer […]
Tags: blood cancer, bone marrow transplant, CAR T cell therapy, chimeric antigen receptor, engineered T cells, immune system, immunotherapy, T cell, UCLA Jonsson Comprehensive Cancer Center
